147 related articles for article (PubMed ID: 19955696)
1. 8-OHdG in cerebrospinal fluid as a marker of oxidative stress in various neurodegenerative diseases.
Gmitterová K; Heinemann U; Gawinecka J; Varges D; Ciesielczyk B; Valkovic P; Benetin J; Zerr I
Neurodegener Dis; 2009; 6(5-6):263-9. PubMed ID: 19955696
[TBL] [Abstract][Full Text] [Related]
2. Systemic increase of oxidative nucleic acid damage in Parkinson's disease and multiple system atrophy.
Kikuchi A; Takeda A; Onodera H; Kimpara T; Hisanaga K; Sato N; Nunomura A; Castellani RJ; Perry G; Smith MA; Itoyama Y
Neurobiol Dis; 2002 Mar; 9(2):244-8. PubMed ID: 11895375
[TBL] [Abstract][Full Text] [Related]
3. Levels of reduced and oxidized coenzyme Q-10 and 8-hydroxy-2'-deoxyguanosine in the cerebrospinal fluid of patients with living Parkinson's disease demonstrate that mitochondrial oxidative damage and/or oxidative DNA damage contributes to the neurodegenerative process.
Isobe C; Abe T; Terayama Y
Neurosci Lett; 2010 Jan; 469(1):159-63. PubMed ID: 19944739
[TBL] [Abstract][Full Text] [Related]
4. The evaluation of oxidative DNA damage in children with brain damage using 8-hydroxydeoxyguanosine levels.
Fukuda M; Yamauchi H; Yamamoto H; Aminaka M; Murakami H; Kamiyama N; Miyamoto Y; Koitabashi Y
Brain Dev; 2008 Feb; 30(2):131-6. PubMed ID: 17766071
[TBL] [Abstract][Full Text] [Related]
5. Increased mitochondrial oxidative damage and oxidative DNA damage contributes to the neurodegenerative process in sporadic amyotrophic lateral sclerosis.
Murata T; Ohtsuka C; Terayama Y
Free Radic Res; 2008 Mar; 42(3):221-5. PubMed ID: 18344116
[TBL] [Abstract][Full Text] [Related]
6. [Urinary 8-hydroxy-2'-deoxyguanosin (8-OHdG) in patients with chronic liver diseases].
Ishizakai M; Yoshida K; Nishimoto N; Saleh AM; Ishii C; Handa H; Ogawara H; Nagamine T; Murakami M; Murakami H
Rinsho Byori; 2004 Sep; 52(9):732-6. PubMed ID: 15552932
[TBL] [Abstract][Full Text] [Related]
7. Circadian variation in multiple sclerosis of oxidative stress marker of DNA damage. A potential cancer marker?
Kanabrocki EL; Ryan MD; Murray D; Jacobs RW; Wang J; Hurder A; Friedman NC; Siegel G; Eladasari B; Nemchausky BA; Cornelissen G; Halberg F
Clin Ter; 2006; 157(2):117-22. PubMed ID: 16817500
[TBL] [Abstract][Full Text] [Related]
8. Increased 8-OHdG levels in the urine, serum, and substantia nigra of hemiparkinsonian rats.
Yasuhara T; Hara K; Sethi KD; Morgan JC; Borlongan CV
Brain Res; 2007 Feb; 1133(1):49-52. PubMed ID: 17188662
[TBL] [Abstract][Full Text] [Related]
9. Plasma and urinary HPLC-ED determination of the ratio of 8-OHdG/2-dG in Parkinson's disease.
Bolner A; Pilleri M; De Riva V; Nordera GP
Clin Lab; 2011; 57(11-12):859-66. PubMed ID: 22239015
[TBL] [Abstract][Full Text] [Related]
10. Increased salivary level of 8-hydroxydeoxyguanosine is a marker of premature oxidative mitochondrial DNA damage in gingival tissue of patients with periodontitis.
Canakçi CF; Canakçi V; Tatar A; Eltas A; Sezer U; Ciçek Y; Oztas S
Arch Immunol Ther Exp (Warsz); 2009; 57(3):205-11. PubMed ID: 19479201
[TBL] [Abstract][Full Text] [Related]
11. Significance of the urinary 8-OHdG level as an oxidative stress marker in lung cancer patients.
Yano T; Shoji F; Baba H; Koga T; Shiraishi T; Orita H; Kohno H
Lung Cancer; 2009 Jan; 63(1):111-4. PubMed ID: 18676055
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid alpha-synuclein in neurodegenerative disorders-a marker of synapse loss?
Ohrfelt A; Grognet P; Andreasen N; Wallin A; Vanmechelen E; Blennow K; Zetterberg H
Neurosci Lett; 2009 Feb; 450(3):332-5. PubMed ID: 19022350
[TBL] [Abstract][Full Text] [Related]
13. Gender- and age-related distinctions for the in vivo prooxidant state in Fanconi anaemia patients.
Pagano G; Degan P; d'Ischia M; Kelly FJ; Pallardó FV; Zatterale A; Anak SS; Akisik EE; Beneduce G; Calzone R; De Nicola E; Dunster C; Lloret A; Manini P; Nobili B; Saviano A; Vuttariello E; Warnau M
Carcinogenesis; 2004 Oct; 25(10):1899-909. PubMed ID: 15192013
[TBL] [Abstract][Full Text] [Related]
14. Effect of repeated intravenous iron administration in haemodialysis patients on serum 8-hydroxy-2'-deoxyguanosine levels.
Maruyama Y; Nakayama M; Yoshimura K; Nakano H; Yamamoto H; Yokoyama K; Lindholm B
Nephrol Dial Transplant; 2007 May; 22(5):1407-12. PubMed ID: 17264097
[TBL] [Abstract][Full Text] [Related]
15. Peripheral oxidative biomarkers constitute a valuable indicator of the severity of oxidative brain damage in acute cerebral infarction.
Liu H; Uno M; Kitazato KT; Suzue A; Manabe S; Yamasaki H; Shono M; Nagahiro S
Brain Res; 2004 Oct; 1025(1-2):43-50. PubMed ID: 15464743
[TBL] [Abstract][Full Text] [Related]
16. Oxidative stress and oxidative DNA damage is characteristic for mixed Alzheimer disease/vascular dementia.
Gackowski D; Rozalski R; Siomek A; Dziaman T; Nicpon K; Klimarczyk M; Araszkiewicz A; Olinski R
J Neurol Sci; 2008 Mar; 266(1-2):57-62. PubMed ID: 17888453
[TBL] [Abstract][Full Text] [Related]
17. Differences in oxidative stress markers based on the aetiology of heart failure: comparison of oxidative stress in patients with and without coronary artery disease.
Nagayoshi Y; Kawano H; Hokamaki J; Uemura T; Soejima H; Kaikita K; Sugiyama S; Yamabe H; Shioji I; Sasaki S; Kuroda Y; Ogawa H
Free Radic Res; 2009 Dec; 43(12):1159-66. PubMed ID: 19905978
[TBL] [Abstract][Full Text] [Related]
18. 8-Hydroxy-2'-deoxy-guanosine is a risk factor for development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection.
Chuma M; Hige S; Nakanishi M; Ogawa K; Natsuizaka M; Yamamoto Y; Asaka M
J Gastroenterol Hepatol; 2008 Sep; 23(9):1431-6. PubMed ID: 18854000
[TBL] [Abstract][Full Text] [Related]
19. Detection of periodontopathic bacteria and an oxidative stress marker in saliva from periodontitis patients.
Sawamoto Y; Sugano N; Tanaka H; Ito K
Oral Microbiol Immunol; 2005 Aug; 20(4):216-20. PubMed ID: 15943765
[TBL] [Abstract][Full Text] [Related]
20. Oxidative stress in pterygium: relationship between p53 and 8-hydroxydeoxyguanosine.
Perra MT; Maxia C; Corbu A; Minerba L; Demurtas P; Colombari R; Murtas D; Bravo S; Piras F; Sirigu P
Mol Vis; 2006 Sep; 12():1136-42. PubMed ID: 17093398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
